Cadila Pharmaceuticals ties up with NovaSAID of Sweden to develop innovative treatments in inflammation and pain management

NovaSAID AB and Cadila Pharmaceuticals Limited have entered into a strategic partnership to develop new treatments for inflammation and pain in conditions such as rheumatoid arthritis. NovaSAID is a company in Karolinska Development's portfolio.
Pain / Anesthetics News From Medical News Today

Share:

Related Content